Tysabri PML Risk-Minimization Strategies Working, Study Finds
Tysabri PML rates are on the decline after preventative guidelines went into effect, according to a new study.
Tag Archives: PML
-
-
Tecfidera Side Effects Could Cause Liver Injury, New Label Warnings Added
New label warnings indicate that the side effects of Tecfidera could cause liver injuries requiring hospitalization.
-
Tecfidera Brain Infection Results in FDA Warning Label Update
The FDA is requiring a new label warning detailing the death of a patient due to brain infection for the MS drug Tecfidera.
-
PML Brain Infection Diagnosed in Gilenya User
A patient taking the multiple sclerosis drug Gilenya has been diagnosed with a rare and often fatal brain infection.
-
Raptiva Recall Lawsuit Trial Over Fatal Infection Delayed
The first trial over claims that the recalled psoriasis drug Raptiva caused a fatal brain infection has been pushed back to June.
-
Tysabri Brain Infection Risk Updated on Drug Label
The label information on the multiple sclerosis drug Tysabri is being updated to reflect new data on the risk of a serious, and sometimes deadly, brain infection that has killed…
-
Raptiva Infection Lawsuit Filed Over Meningitis and Acute Retinal Necrosis
A Raptiva infection lawsuit has been filed by a Massachusetts man who claims that the recalled psoriasis drug caused him to develop meningitis and acute retinal necrosis, which left him…
-
Raptiva Lawsuit Filed By User Who Developed Lymphoma
A Texas man who was diagnosed with classic Hodgkin’s lymphoma has filed a Raptiva lawsuit, alleging that the recalled psoriasis drug caused him to develop the cancer.
-
Tysabri Linked to Serious Brain Infection PML in 79 People, 16 Deaths
According to new data released by Biogen Idec, their once-recalled multiple sclerosis drug Tysabri has been linked to at least 79 confirmed cases of progressive multifocal leukoencephalopathy (PML), including at…
-
FDA Warns Drug Maker For Minimizing Risk of Brain Infection from Tysabri
Federal regulators have cited Biogen Idec, Inc. for attempting to downplay the risks of a rare, but often fatal, brain infection that has been linked to the multiple sclerosis drug…
